DALLAS, December 8, 2014 /PRNewswire/ --
According to the new market research report "Allergy Diagnostics Market by Allergen Source (Food Allergens, Inhaled Allergens), by Product (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables), by End User (Hospital, Diagnostic Laboratory) - Global Forecast to 2019", published by MarketsandMarkets, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global allergy diagnostics market along with the estimates and forecasts of the revenue and market share analysis.
Browse 73 market data tables and 105 figures spread through 210 pages and in-depth TOC on "Allergy Diagnostics Market"
Early buyers will receive 10% customization on this report.
The global Allergy Diagnostics Market is valued at $1,228.58 Million in 2014. This market is expected to grow at a CAGR of 12.67% to reach $2,230.72 Million in 2019.
The global Allergy Diagnostics Market is segmented on the basis of allergen, end user, product, and geography. By allergen, the market is divided into food allergens, inhaled allergens, and other allergens. Of these, the inhaled allergens segment accounted for the largest share of the global Allergy Diagnostics Market in 2014. The end-user segments included in this report are academic research institutes, diagnostics laboratories, hospitals, and other end users. By products, the market is segmented into assay kits, consumables, and instruments.
The instruments product segment is further subsegmented into immunoassay analyzers, luminometers, and other instruments. Of these, the immunoassay analyzers subsegment is expected to hold the largest share of the global allergy diagnostic instruments market in 2014, and is poised to grow at the highest CAGR between 2014 and 2019.
The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The Asian segment is further divided into China, India, Japan, and the Rest of Asia. Europe is divided into France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada and the U.S. The RoW encompasses Africa; Pacific and Oceania; and South America, Central America, and the Caribbean.
Rapidly increasing incidence of allergic diseases and rising environmental pollution will be important growth drivers for this market during the forecast period. Furthermore, the large proportion of children aged below 14 years, who are at a higher risk developing allergic disorders, will be an important driver for allergy diagnostics market.
Major players in the Allergy Diagnostics Market include B BioMérieux (France), Danaher Corporation (U.S.), Hitachi Chemical Diagnostics (U.S.), HOB Biotech Group (China), Hycor Biomedical (U.S.), Lincoln Diagnostics (U.S.), Omega Diagnostics (U.K.), Siemens Healthcare (Germany), Stallergenes (France), and Thermo Fisher Scientific (U.S).
Browse related reports
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018
Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog http://mnmblog.org/market-research/healthcare/medical-devices